Carol Adiletto Appointed Vice President, Clinical and Regulatory Affairs10/20/2008Waltham, Mass. – BG Medicine Inc, (BGM) today announced that Carol Adiletto has joined the organization as Vice President of Clinical and Regulatory Affairs. Ms. Adiletto will be responsible for the management of all clinical and regulatory activities, as well as further development of BGM’s regulatory strategy. Prior to joining, BGM, Ms. Adiletto served as Sr. Vice President of Clinical Operations and Regulatory Affairs at WorldCare Clinical, LLC and Vice President of Clinical and Regulatory at Inverness Medical Innovations, Inc. She has lead clinical and regulatory teams in strategy and execution of clinical trials and global regulatory submission efforts for a number of medical diagnostic and device products. Ms. Adiletto holds an M.S. in Medical Laboratory Science with a Clinical Chemistry Specialization and a B.S. in Medical Laboratory Science from Northeastern University. “The diagnostic industry is in rapid transformation and growth driven by novel content”, said Carol Adiletto “The combination of its broad and innovative partnerships and unique technology platform positions BG Medicine well to become one of the leading new generation IVD companies”. “During her years as Director and VP of Clinical and Regulatory at Inverness Medical, Carol played an important role in establishing Inverness as one of the leading in-vitro diagnostic companies.” said President and CEO Pieter Muntendam. This wealth of experience will enable Carol to lead the clinical and regulatory activities for our innovative diagnostics in cardiology and other therapeutic areas. About BG Medicine
|